MIRA
INFORM REPORT
|
Report Date : |
26.06.2007 |
IDENTIFICATION DETAILS
|
Name : |
ANZEN EXPORTERS |
|
|
|
|
Registered Office : |
55/3D, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.03.2007 |
|
|
|
|
Date of Incorporation : |
1990 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
CALA03133E |
|
|
|
|
Legal Form : |
Sole Proprietory Concern |
|
|
|
|
Line of Business : |
Traders, Importers, Exporters and Agents for Pharmaceutical Bulk Drugs |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
Maximum Credit Limit : |
-- |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established proprietory concern engaged in the business as importers, exporters and traders of bulk drugs. The proprietor is a resourceful businessman having business interest in other company doing similar business. The concern’s business as progressing satisfactorily, making reasonably good profits. Trade relations are reported as fair. Payments are usually made as per commitments. The concern can be considered normal for business dealings
at usual trade terms and conditions |
LOCATIONS
|
Registered Office : |
55/3D, |
|
Tel. No.: |
91-33-24614728 / 4741 / 24659650 / 51 |
|
Fax No.: |
91-33-24658159 |
|
E-Mail : |
|
|
Website: |
|
|
Area : |
400sq.fts |
|
Location : |
Leased |
|
|
|
|
Head Office : |
157, |
|
Tel. No.: |
91-33-24659650/51 |
|
Fax No.: |
91-33-24658159 |
|
Mobile No. : |
91-33-9830021710 |
|
Area : |
600sq.fts |
|
Location : |
Rented |
|
|
|
|
Mumbai office: |
207, Laxmi Industrial
Estate, New |
|
Tel No.: |
91-222634 4608 /
09 /10 |
|
Fax No.: |
91-22-26318808 |
|
E-Mail: |
|
|
|
|
SOLE PROPRIETOR
|
Name : |
Mr. Manish Jajodia |
|
Designation : |
Proprietor |
|
Address : |
55/3D, |
|
Date of Birth/Age : |
10.08.1970 |
|
Qualification : |
B. Com |
|
Experience : |
15 Years |
KEY EXECUTIVES
|
Name : |
Mr. J K Jajodia |
|
Designation : |
Chief Executive |
|
|
|
|
Name : |
Mr. Ashish Jajodia |
|
Designation : |
Executive |
|
|
|
|
Name : |
Ms. Minu Jajodia |
|
Designation : |
Excecutive |
|
|
|
|
Name : |
|
|
Designation : |
Mrs. Mahua Das |
|
Address : |
Executive |
BUSINESS DETAILS
|
Line of Business : |
Traders, Importers, Exporters and Agents for Pharmaceutical Bulk Drugs |
|
|
|
|
Products : |
· Alendronate Sodium · Amitriptyline HCL · Alprazolam · Aluminium Hydroxide Gel (Dried) · Bambuterol · Betamethasone & Salts · Cetrizine Director HCL · Cefexime · Cefachlor · Chloramphenicol Palmitate · Chlorhexidine Gluconate · Clonazepam · Citalopram HBR · Domepridone Base/Maleate · Dexamethasone and Salts · Dexchlorpheniramine Maleate · Enalapril Maleate · Esomeprazole Magnessium · Famotidine · Fluxetine HCL · Flunnarizine HCL · Gliben Clamide · Haloperidol · Itraconazole Powder and Pellets · Lamotrigine · Lansoprazole Powder and Pellets · Lamidvudine · Levocetrizine · Magaldrate · Mebendazole USP · Metformin HCL · Nimesulide · Olanzapine · Omeprazole Powder and Pellets · Ambroxol HCL/Base · Amlodipine Besylate · Atorvastatin Calcium · Atenolol · Bisacodyl · Buflomedil · Active Pharmaceuticals Ingredients · Finished Dosages · Indented Products |
|
|
|
|
Agencies Held : |
v
Aurobindo Pharma Limited, v Lupin Limited, Vadodara v Torrent Gujarat Biotech Limited, Vadodara v Alembic Limited v
Jaingsu Guotai International, v
Fujian Fukang Pharmaceutical Company Limited, v Zhejiang Zhebei Pharmaceutical Company Limited Syntech Chem and Pharm Company Limited, |
|
|
|
|
Exports : |
|
|
Products : |
Pharmaceutical bulk drugs |
|
Countries : |
Brazil, Argentian, Chile, Peru, Colombia, Mexico, Belgium, Spain, UK, Germany, Thailand, Indonesia, Vietnam, Pakistan, Romania, Syria, Egypt, Iran, Sri Lanka and Canada. |
|
|
|
|
Imports : |
|
|
Products : |
Bulk drugs and intermediates |
|
Countries : |
|
|
|
|
|
Terms : |
|
|
Selling : |
L/C, Cash or Credit (90 to 120 days) |
|
|
|
|
Purchasing : |
L/C, Cash, Credit, D/A or D/P |
GENERAL INFORMATION
|
Customers : |
Wholesalers, Retailers and End Users |
|
|
|
|
No. of Employees : |
15 |
|
|
|
|
Bankers : |
©
Standard Chartered Bank
Kolkata and Mumbai © ABN Amro Bank ©
ABN Amro Bank, Mumbai, |
|
|
|
|
Facilities : |
C/C and L/C – Rs.18.000 millions (Standard Chartered Bank) |
|
|
|
|
Banking
Relations : |
Satisfactory |
|
|
|
|
Auditors : |
|
|
Name : |
Pande and Associates Chartered Accountants |
|
Address : |
50, |
|
|
|
|
Memberships: |
CHEMEXCIL, PHARMEXCIL |
|
|
|
|
Associates/Subsidiaries : |
Shubham Pharmachem Private Limited 207, Laxmi Industrial Estate, Line of Business: Trading |
CAPITAL STRUCTURE
NA
FINANCIAL DATA
[all figures are
in Rupees Millions]
|
Particulars |
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
Sales Turnover |
100.000 |
80.000 |
46.220 |
|
|
|
|
|
|
Profit/Loss for the year |
NA |
NA |
0.466 |
|
|
|
|
|
|
Export Value |
NA |
NA |
4.620 |
|
|
|
|
|
|
Import Value |
NA |
NA |
6.000 |
Expected Sales (2007-08) : Rs.150.000 millions
LOCAL AGENCY FURTHER INFORMATION
It is in trade terms
with-
· Dey’s Medical Stores (Manufacturing) Limited
· Albert David Limited
·
· Stressenburg Pharmaceuticals Limited
COMPANY PROFILE
Anzen Exports was
incorporated in 1990 under the leadership of Mr. J K Jajodia. The company
strides to achieve global standards in the field of Pharmaceuticals and bulk
drugs. Anzen Exports initially started with domestic trading in bulk drugs and
gradually ventured into the areas of export, imports, and indenting. Constant
diversification and expansion of business activities has resulted in creation
of large clientele in domestic and international markets and is a contributing
factor for the high turnover rate which rose by 400% in the last decade.
MANAGEMENT
Mr. J K Jajodia, Rajesh
Jajodia, and Ashish Jajodia manage the domestic trading of bulk drugs. Manish
Jajodia is responsible for the export business of the company while Rajesh
Jajodia is responsible for the export of finished dosages. Jaya Jajodia and
Manish Jajodia manage the imports and indenting business
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals have
been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.40.81 |
|
|
1 |
Rs.81.57 |
|
Euro |
1 |
Rs.54.91 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
4 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
45 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|